Acrivon Therapeutics (ACRV) Shares Outstanding (Entity) (2021 - 2026)
Acrivon Therapeutics (ACRV) posted Shares Outstanding (Entity) of 42.85 million for Q2 2026, up 36.2% from 31.45 million a year earlier and up 10.6% from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Shares Outstanding (Entity) (2021 - 2026) Analysis & Trends
For FY2025, Acrivon Therapeutics' Shares Outstanding (Entity) came in at 31.65 million, up 1.3% from FY2024.
- Annual Shares Outstanding (Entity) has increased for four consecutive years, with a four-year compound annual growth rate of 105.6% (FY2021 to FY2025).
- In prior years, Acrivon Therapeutics' Shares Outstanding (Entity) was 31.23 million in FY2024 (+38.7%), 22.52 million in FY2023 (+446.4%), 4.12 million in FY2022 (+132.9%) and 1.77 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Shares Outstanding (Entity) in data going back to Q3 2021.
- On a year-over-year basis, Shares Outstanding (Entity) has increased in each of the last 11 quarters, with growth averaging 22.8% over the last eight quarters.
- The year-over-year growth in Shares Outstanding (Entity) has ranged between 0.5% (Q3 2022) and 446.4% (Q4 2023) over the last five years.
- According to Business Quant data, Shares Outstanding (Entity) for the three prior quarters was 38.75 million (Q1 2026), 31.65 million (Q4 2025) and 31.55 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Acrivon Therapeutics | 87.84 Mn | 87.84 Mn | - | 42.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.85 Mn |
| Mar 31, 2026 | 38.75 Mn |
| Dec 31, 2025 | 31.65 Mn |
| Sep 30, 2025 | 31.55 Mn |
| Jun 30, 2025 | 31.45 Mn |
| Mar 31, 2025 | 31.35 Mn |
| Dec 31, 2024 | 31.23 Mn |
| Sep 30, 2024 | 31.13 Mn |
| Jun 30, 2024 | 30.97 Mn |
| Mar 31, 2024 | 22.64 Mn |
| Dec 31, 2023 | 22.52 Mn |
| Sep 30, 2023 | 22.10 Mn |
| Jun 30, 2023 | 22.07 Mn |
| Mar 31, 2023 | 21.92 Mn |
| Dec 31, 2022 | 4.12 Mn |
| Sep 30, 2022 | 1.78 Mn |
| Jun 30, 2022 | 1.77 Mn |
| Mar 31, 2022 | 1.77 Mn |
| Dec 31, 2021 | 1.77 Mn |
| Sep 30, 2021 | 1.77 Mn |
API Access
Acrivon Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();